BPC-157 and TB-500 in One Vial: 530 Daltons Apart
Send this vial through a gradient and the chromatogram comes back lopsided: a narrow peak early, a visibly wider one later. It reads like something misfired. Nothing did. That difference in shape is built into the pair.
Why the trace looks uneven
Fifteen residues on one side and seven on the other, with little chemistry shared between them. BPC-157 runs three prolines back to back and carries two aspartates alongside a glutamate. TB-500 is acetylated at the N-terminus and carries two lysines and a glutamate.
Being shorter and more polar, TB-500 generally comes off first on an ordinary water-acetonitrile gradient. That run of prolines in BPC-157 broadens its peak in a characteristic way, worked through in the proline cis-trans article. Sharp and early, then broad and late, is consequently the expected picture rather than a symptom of anything.
What the number on the label counts
Equal masses of the two compounds, mixed as solutions and freeze-dried together afterwards. Ten milligrams on a vial means five and five. Twenty means ten and ten. The figure totals two compounds; it is not a quantity of either one.
| Compound | Sequence | Formula | Mass | CAS |
| BPC-157 | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | C62H98N16O22 | 1419.5 g/mol | 137525-51-0 |
| TB-500 | Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln | C38H68N10O14 | 889.0 g/mol | 885340-08-9 |
A point of nomenclature belongs here too. TB-500 is an acetylated seven-residue fragment matching the 17 to 23 stretch of thymosin beta-4, and it is not the 43-residue protein. Thymosin beta-4 versus the TB-500 fragment sets out that difference.
530 daltons is an enormous margin
Around 530 daltons stand between the two masses, which by the standards of mixture analysis is luxurious. Protonate each once and the ions land near m/z 1420.5 and near 890.0. Go to the doubly charged pair and they sit near 710.8 and 445.5, just as far from one another.
Resolving them is not a difficulty. Any instrument fit for peptide work will report both separately, which means a spectrum of this material showing only one mass is reporting a problem with the sample rather than a limit of the method.
Areas are not proportions
Integrating the two peaks and reading off a mass ratio is the obvious move, and it does not work. Ultraviolet response at 214 nm follows the count of peptide bonds, and those counts are fourteen for BPC-157 against six for TB-500.
Per milligram, therefore, BPC-157 lays down more area, and an honest equal-mass vial yields a trace on which the larger compound appears over-represented. Converting area into mass means determining a response factor against a reference standard for each component, which is calibration work rather than integration. What one vial of several compounds can and cannot tell you takes up the general case.
A mixture owns no stability profile
It borrows the shorter of the two it holds. Here, both are reasonably durable. Cysteine and methionine appear in neither sequence, so the usual oxidation routes have nothing to act on. The two aspartates in BPC-157 can close into a succinimide and isomerize from there. Glutamate and glutamine residues are present across the pair, and those deamidate slowly.
Once reconstituted the compounds occupy a single solution, so any condition that degrades one is being applied to the other simultaneously. Dividing into aliquots and freezing them, instead of going back into the same vial again and again, is the standard precaution; aliquoting and vial entry describes it.
Mixed before drying, and that is irreversible
Since the two went together as solutions ahead of lyophilization, the cake is homogeneous and not layered. Short of a preparative separation, nothing will recover either compound from it alone.
Hence both being stocked on their own as well: BPC-157 and TB-500 as single-compound vials, with the mixed presentations at 10 mg total and 20 mg total.
What a document for a two-component lot must say
Identity stated component by component, never for the mixture as a unit. A sequence, a formula, a mass and a registry number apiece, plus a chromatogram on which retention against standards has assigned both peaks. Both masses, 1419.5 and 889.0, genuinely observed rather than merely expected.
Composition given in milligrams per component instead of a total standing by itself. And no single purity percentage, since the second peak is a constituent the product specifies rather than an impurity that crept in, which leaves one figure for the whole vial without meaning. Nobody should expect the peak areas to track the mass ratio either, for the reason given above.
